COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
- 1 September 2021
- journal article
- letter
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 27 (9) , 1376-1378
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patientsClinical Microbiology and Infection, 2020
- Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case seriesJournal of Critical Care, 2020
- Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric ExperienceJournal of Fungi, 2020
- COVID-19 and fungal superinfectionThe Lancet Microbe, 2020
- COVID-19–associated Pulmonary AspergillosisAmerican Journal of Respiratory and Critical Care Medicine, 2020
- COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: An observational study from PakistanMycoses, 2020
- Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case seriesCritical Care, 2020
- COVID-19-associated invasive pulmonary aspergillosisAnnals of Intensive Care, 2020
- Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19The Lancet Respiratory Medicine, 2020
- COVID‐19 associated pulmonary aspergillosisMycoses, 2020